arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

ROCKWELL MEDICAL, INC.

RMTI
$7.67 ▼ -0.43 (-5.31%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
68 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
32
Health
Poor
Bearish
auto_awesome

Analytical Summary

ROCKWELL MEDICAL, INC. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $30.4M
Dividend Yield —
Revenue Growth 10.6% ↗
Op. Margin -6.0% ↗
ROIC -2.0% ↗
FCF / Share $0.53 ↗
Trailing P/E —
Price / Book 0.9x
FCF Yield 6.9%
Debt / Equity 0.21
info Valuation on last close. End-of-day price, Nov 5, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$17.78M
↑ +10.6% —
Net Income Profit after all expenses
$-1.60M
↓ -5.9% —
Operating Margin Operating profit as % of sales
-6.0%
↑ +30.1% 18th
FCF / Share Free cash flow per share
$0.53
↑ +12502.4% —
Long-Term Debt Long-term obligations
$7.24M
↓ -11.8% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
20
Returns ↑
31
Financial Health →
52
Cash Quality ↓
26

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 68 quarters